CDP 1050

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCDP 1050
Drug Alias NameCDP-1050
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRyanodine receptor calcium release channel modulatorsNitric oxide donorsReactive oxygen species inhibitors
TargetsRyanodine receptor 3Ryanodine receptor 2Ryanodine receptor 1
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins UniversityDuke-Nus
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCordexDuke-NusJohns Hopkins University
Active IndicationsN/A
Inactive IndicationsHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A